SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential acquisition, with Paramount Skydance reportedly preparing a $71 billion bid. The community is discussing the likelihood of a bidding war, potential involvement of other major players like Netflix and Comcast, and the possible impact of regulatory hurdles. Community talking points include speculation around a potential overbid. 

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as investors discuss a recent European contract win and the closing of the Sentrycs acquisition, anticipating positive impacts on revenue and market position. The community is weighing the potential for further gains against concerns about potential share dilution related to these deals. Bullish sentiment is fueled by long-term growth prospects in the drone and counter-UAS sectors, despite some volatility.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance ($PSKY) is trending amid speculation around a potential bid for Warner Bros. Discovery ($WBD), with community chatter focusing on deal terms and potential involvement of Saudi investors. Some traders believe the outcome will heavily influence $PSKY's valuation, while others suggest the company should focus on internal growth rather than acquisitions. Community members are closely watching for a confirmed offer and discussing potential price targets based on various scenarios.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending following positive data from Roche on a similar breast cancer drug, sparking significant intraday volatility and a surge in price. The community is actively debating whether this jump is justified, discussing potential short squeezes, imminent offerings, and the overall valuation of OLMA in light of the news. Some traders are wary of a potential pullback, while others see further upside based on pipeline potential and analyst upgrades.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as investors discuss the company's recent technology upgrade for quantum algorithm simulation, highlighting its compatibility with NVIDIA's CUDA-Q. Community members are focused on the potential for accelerated quantum computing and BTQ's positioning in the sector, with some speculating about partnerships and future growth prospects.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

MCRB is trending amid ongoing speculation of a potential acquisition by Nestl, with community chatter focusing on the timing and likelihood of a deal. Recent workforce reductions and executive departures have fueled rumors, while some traders point to technical indicators suggesting a potential short squeeze. Uncertainty persists around the company's strategic direction and whether it will pursue a partnership instead of a buyout.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet (STRK) is trending as analysts highlight its breakout from a rounding-bottom pattern and potential Wave 3 run, with some targeting $0.50. Community excitement is fueled by growing BTCFi integration, increased staking volume, and the network's focus on quantum-resistant technology. Discussions also focus on Starknet's strong performance compared to other Layer-2 solutions and its growing ecosystem.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions about the impending release of Epstein files and their potential impact on the stock and Donald Trump. The community is split, with some investors expressing concern over potential implications, while others remain supportive, viewing it as a buying opportunity. Broader market anxieties and the stock's performance are also contributing to the ongoing conversation.

Recall is a decentralized skill market for AI where communities fund, rank, and discover the AI solutions they need. Instead of corporations pushing one-size-fits-all AI, Recall flips the dynamic—communities signal demand, developers compete to deliver, and performance determines visibility.

Recall

RECALL is trending as community members discuss its potential as a new AI-focused crypto project built on Base with backing from Coinbase Ventures. Chatter revolves around its hourly chart, possible breakout zones, undervalued status and decentralized AI competition platform, while some caution about potential risks associated with new crypto projects.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following FDA approval of their first drug, REDEMPLO, for a rare genetic disorder, Familial Chylomicronemia Syndrome (FCS). The community is excited about the potential for revenue generation and the validation of their RNAi platform, with some anticipating a valuation reset and potential for significant upside. Discussions also highlight the drug's competitive advantages, pipeline, and possible expansion into broader indications.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
